Abstract
Sickle cell anemia (SCA) is a genetic disease belonging to the sickle cell group, determined by homozygous hemoglobin S - Hb SS and is characterized by the form of greater clinical severity, being also the most prevalent. The only treatment with curative possibility for sickle cell anemia is Hematopoietic Stem Cell Transplantation (HSCT). HSCT has an important impact on patients' lives, a…